Berger's disease treatment gains orphan status

04:37 EDT 11 Aug 2017 | SmartBrief

The FDA gave orphan designation to Anthera Pharmaceuticals' blisibimod to treat immunoglobulin A nephropathy, or Berger's dis -More

Original Article: Berger's disease treatment gains orphan status


More From BioPortfolio on "Berger's disease treatment gains orphan status"

Quick Search

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...